In vitro cell-culture study demonstrates that fenofibrate (used as adjunct to statins to lower cholesterol and lipid levels) reduces severity of coronavirus infection. Human trials to follow to determine if this holds true in vivo. #GoScience

Dr. Barry Dworkin

Medical Mythbusting Commentary for August 9, 2021

[display_podcast]

Source:
Cholesterol drug cuts coronavirus infection by 70%, researchers find

Reference:
The Hyperlipidaemic Drug Fenofibrate Significantly Reduces Infection by SARS-CoV-2 in Cell Culture Models

Related posts:

  1. Old antipsychotic medication helps kill Methicillin Resistant Staph Aureus (MRSA)
  2. Inappropriate antibiotic prescriptions given out more than half the time for colds
  3. PM Trudeau, your flouting of pandemic health policy rules demoralizes the country. Armchair “physicians”, stop flaunting cherry-picked preprint studies as “the” evidence HCQ works when there are just as many that refute it. That is why proper investigation and meta-analysis are required.
  4. Heparin seems to reduce progression of COVID-19 in hospitalized people with moderate symptoms but not for the critically ill. Study author states that more research required to find the therapeutic “sweet spot”.